U.S.: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in the U.S.

The U.S. medicaments containing corticosteroid hormones market soared to $X in 2021, increasing by 17% against the previous year. In general, the total consumption indicated a strong increase from 2012 to 2021: its value increased at an average annual rate of +5.8% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +81.9% against 2013 indices. Over the period under review, the market attained the peak level in 2021 and is likely to see gradual growth in the near future.

Production of Medicaments Containing Corticosteroid Hormones in the U.S.

In value terms, medicaments containing corticosteroid hormones production rose remarkably to $X in 2021. The total output value increased at an average annual rate of +1.9% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2017 when the production volume increased by 38% against the previous year. Over the period under review, production hit record highs at $X in 2018; however, from 2019 to 2021, production stood at a somewhat lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports from the U.S.

After two years of growth, overseas shipments of medicaments containing corticosteroid hormones decreased by -3.6% to X tons in 2021. Overall, exports showed a relatively flat trend pattern. The growth pace was the most rapid in 2017 when exports increased by 25% against the previous year. Over the period under review, the exports reached the maximum at X tons in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.

In value terms, medicaments containing corticosteroid hormones exports expanded markedly to $X in 2021. Over the period under review, total exports indicated a resilient increase from 2012 to 2021: its value increased at an average annual rate of +6.7% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +123.4% against 2016 indices. The most prominent rate of growth was recorded in 2019 when exports increased by 39%. Over the period under review, the exports hit record highs in 2021 and are expected to retain growth in the immediate term.

Exports by Country

Canada (X tons), Japan (X tons) and France (X tons) were the main destinations of medicaments containing corticosteroid hormones exports from the United States, with a combined 37% share of total exports. Mexico, Saudi Arabia, Australia, Italy, Switzerland, Brazil, Denmark, the Netherlands, the UK and South Korea lagged somewhat behind, together comprising a further 43%.

From 2012 to 2021, the biggest increases were recorded for Denmark (with a CAGR of +227.8%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Canada ($X), France ($X) and Japan ($X) were the largest markets for medicaments containing corticosteroid hormones exported from the United States worldwide, with a combined 37% share of total exports. Italy, Brazil, Australia, Saudi Arabia, the Netherlands, Mexico, Switzerland, the UK, South Korea and Denmark lagged somewhat behind, together comprising a further 38%.

In terms of the main countries of destination, Denmark, with a CAGR of +221.1%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average medicaments containing corticosteroid hormones export price amounted to $X per ton, jumping by 15% against the previous year. Overall, export price indicated prominent growth from 2012 to 2021: its price increased at an average annual rate of +7.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments containing corticosteroid hormones export price increased by +43.9% against 2017 indices. The growth pace was the most rapid in 2014 an increase of 54% against the previous year. Over the period under review, the average export prices hit record highs in 2021 and is expected to retain growth in the immediate term.

Prices varied noticeably country of destination: the country with the highest price was France ($X per ton), while the average price for exports to Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Italy (+25.8%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports into the U.S.

In 2021, approx. X tons of medicaments containing corticosteroid hormones were imported into the United States; picking up by 4.5% compared with the previous year. Overall, total imports indicated buoyant growth from 2012 to 2021: its volume increased at an average annual rate of +5.8% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +48.3% against 2017 indices. The most prominent rate of growth was recorded in 2020 with an increase of 22% against the previous year. Imports peaked in 2021 and are likely to continue growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones imports rose significantly to $X in 2021. Over the period under review, total imports indicated a resilient increase from 2012 to 2021: its value increased at an average annual rate of +7.9% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +105.9% against 2013 indices. The pace of growth was the most pronounced in 2019 when imports increased by 21% against the previous year. Imports peaked in 2021 and are expected to retain growth in the immediate term.

Imports by Country

In 2021, Canada (X tons) constituted the largest supplier of medicaments containing corticosteroid hormones to the United States, accounting for a 33% share of total imports. Moreover, medicaments containing corticosteroid hormones imports from Canada exceeded the figures recorded by the second-largest supplier, India (X tons), twofold. The third position in this ranking was taken by France (X tons), with an 11% share.

From 2012 to 2021, the average annual rate of growth in terms of volume from Canada totaled +7.1%. The remaining supplying countries recorded the following average annual rates of imports growth: India (+19.4% per year) and France (+1.9% per year).

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing corticosteroid hormones to the United States, comprising 43% of total imports. The second position in the ranking was held by Ireland ($X), with a 21% share of total imports. It was followed by France, with a 3.8% share.

From 2012 to 2021, the average annual rate of growth in terms of value from Denmark totaled +16.0%. The remaining supplying countries recorded the following average annual rates of imports growth: Ireland (+22.4% per year) and France (-8.1% per year).

Import Prices by Country

The average medicaments containing corticosteroid hormones import price stood at $X per ton in 2021, rising by 6.1% against the previous year. Over the last nine-year period, it increased at an average annual rate of +2.0%. The growth pace was the most rapid in 2015 an increase of 11%. The import price peaked at $X per ton in 2019; however, from 2020 to 2021, import prices stood at a somewhat lower figure.

Prices varied noticeably country of origin: the country with the highest price was Denmark ($X per ton), while the price for Canada ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Netherlands (+13.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :